Jennifer Maas

Jennifer Maas is a clinical research professional with over 20 years of experience in the healthcare and biotechnology industries, specializing in quality assurance, clinical data management, and project oversight. At Global BioClinical (GBC), Mrs. Maas brings a deep commitment to quality, operational efficiency grounded in hands-on experience, and a meticulous attention to detail.

Prior to joining GBC, Mrs. Maas served as Clinical Study Manager at Epigenomics AG, where she led multiple clinical trials and was responsible for the oversight of biorepository operations, biospecimen informatics, and biomarker discovery – including clinical study operations focused on colon cancer, lung cancer, and prostate cancer. Her work ensured data integrity and regulatory alignment across global diagnostic studies.

Earlier in her career, Mrs. Maas held the role of Quality Control Specialist at the Northwest Tissue Center in Seattle, WA. There, she managed transplant tissue processing documentation, tracked and resolved operational deviations, and conducted audits of both internal procedures and external vendor processes to ensure compliance with FDA regulations, industry standards, and internal standard operating procedures (SOPs).